OpenVSafe by OpenVAERS
Search V-safe

5XN-25500-57971

3 vaccinations 2 coded responses 21 check-ins 2 free-text entries 0 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
950 / CA
Registered
2021-03-03
Relationship
Self
Race
Multiracial
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-02-09
    Dose 1 — Pfizer-BioNTech
  2. 2021-03-01
    Dose 2 — Pfizer-BioNTech
  3. 2021-03-03
    Registered in v-safe
  4. 2021-03-03
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  5. 2021-03-04
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  6. 2021-03-05
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Headache, Fatigue or tiredness, Nausea
    Adult check-in
  7. 2021-03-06
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Itching · Headache, Fatigue or tiredness
    Adult check-in
  8. 2021-03-07
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Itching · None
    Adult check-in
  9. 2021-04-12
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  10. 2021-05-31
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  11. 2021-08-30
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  12. 2022-01-04
    Dose 3 — Pfizer-BioNTech
  13. 2022-01-05
    Survey response — days 1–6 daily, dose 3
    MedDRA: Pregnancy — Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Pregnant
    MedDRA releases: 2024-11 · check-in free text available
  14. 2022-01-07
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain, Swelling · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activities
    Adult check-in
  15. 2022-01-09
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · Headache
    Adult check-in
  16. 2022-01-10
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Headache
    Adult check-in
  17. 2022-01-12
    Health check-in — day 7, dose 3
    Feeling: Fair · Headache, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activities
    Adult check-in
  18. 2022-01-18
    Survey response — day 14, dose 3
    MedDRA: Malaise, Nasopharyngitis, SARS-CoV-2 test — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Sick with a cold or possible COVID (awaiting test results)
    MedDRA releases: 2024-11 · check-in free text available
  19. 2022-01-27
    Health check-in — day 21, dose 3
    Feeling: Good
    Adult check-in
  20. 2022-02-01
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  21. 2022-02-08
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  22. 2022-02-15
    Health check-in — day 42, dose 3
    Feeling: Fair
    Adult check-in
  23. 2022-04-06
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  24. 2022-07-05
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  25. 2023-01-04
    Health check-in — 12 months, dose 3
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-02-09Pfizer-BioNTech
22021-03-01Pfizer-BioNTech
32022-01-04Pfizer-BioNTech No

Free text

Release 10 — days 1–6 daily, dose 3

2022-01-05

Systemic reaction (other): Pregnant

Release 10 — day 14, dose 3

2022-01-18

Symptoms: Sick with a cold or possible COVID (awaiting test results)

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDMalaise · · ✓
SDNasopharyngitis · · ✓
SDSARS-CoV-2 test · · ✓
SROPregnancy · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release